EDIT
Editas Medicine, Inc.
A biotech company that develops treatments for serious diseases by editing genes with CRISPR, a molecular tool that snips and rewrites DNA. Founded in 2013 in Cambridge, Massachusetts, it was started by pioneers of the field including Jennifer Doudna and Feng Zhang, and its name comes from the Latin word "edit." Its medicines aim at inherited conditions such as blood disorders and cardiovascular disease.
CUSIP: 28106W103HealthcareUS3 holders
Total Value
$490.11M
Total Shares
11.83M
Net Share Change
-2.28M
Activity
3 selling
Investor
Value
Shares
Weight
Change
